Wellington Management Group LLP Cti Biopharma Corp Transaction History

Wellington Management Group LLP

  • $557 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$4.2 - $6.01 $1.1 Million - $1.58 Million
262,655 Added 9.52%
3,021,558 $12.7 Million
Q4 2022

Feb 13, 2023
SELL
$4.45 - $6.17 $270,382 - $374,889
-60,760 Reduced 2.15%
2,758,903 $16.6 Million
Q3 2022

Nov 14, 2022
BUY
$5.36 - $7.43 $6.89 Million - $9.56 Million
1,286,193 Added 83.87%
2,819,663 $16.4 Million
Q2 2022

Aug 15, 2022
BUY
$3.55 - $6.27 $5.44 Million - $9.61 Million
1,533,470 New
1,533,470 $9.16 Million

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email